Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FU

Zhou, RH; Wu, J; Tang, XF; Wei, X; Ju, C; Zhang, FF; Sun, J; Shuai, DY; Zhang, ZP; Liu, Q; Lv, XB

Lv, XB (reprint author), Nanchang Univ, Affiliated Hosp 3, Nanchang Key Lab Canc Pathogenesis & Translat Res, 128 Xiangshan Northern Rd, Nanchang 330008, Jiangxi, Peoples R China.; Liu, Q (reprint author), Cent S Univ, Xiangya Hosp, Dept Cardiovasc Med, 8

ONCOLOGY LETTERS, 2018; 16 (2): 1967

Abstract

AR-42 is a member of a novelly discovered class of phenylbutyrate-derived histone deacetylase inhibitors, and has a number of antitumor effects in a v......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索